Richard Ogawa, Director (NONE), bought 108,334 shares at $1.20 ($130K) on 2018-04-27, disclosed to the SEC on 2018-05-01.
Open-market purchase of $130k NONE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 25,000 | $30K | 23.1% |
| 2 | $1.20 | 41,667 | $50K | 38.5% |
| 3 | $1.20 | 41,667 | $50K | 38.5% |
| Total | $1.20 avg | 108,334 | $130K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | $50K | — | Filing → |
| AMST | BUY |
| 2021-12-03 |
| $22K |
| — |
| Filing → |
| AMST | BUY | 2020-09-29 | $20K | — | Filing → |
| IPHI | SELL | 2020-04-27 | $395K | — | Filing → |
| IPHI | SELL | 2020-04-22 | $1.2M | — | Filing → |